Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

被引：68

作者：

Feldman, SR

Kimball, AB

Krueger, GG

Woolley, JM

Lalla, D

Jahreis, A

机构：

[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27157 USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

[3] Brigham & Womens Hosp, Boston, MA 02115 USA

[4] Utah Hlth Sci Ctr, Salt Lake City, UT USA

[5] Amgen Inc, Thousand Oaks, CA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 53卷 / 05期

关键词：

D O I：

10.1016/j.jaad.2005.06.053

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In this randomized, double-blind, phase III trial, patients with psoriasis received etanercept for 24 weeks or placebo for 12 weeks followed by etanercept for 12 weeks. At week 12, improvement in Dermatology Life Quality Index was 47% to 61% with etanercept compared with 11% with placebo (P <.0001). Etanercept rapidly and substantially improved patients' health-related quality of life.

引用

页码：887 / 889

页数：3

共 50 条

[1] Etanercept improves health-related quality of life in rheumatoid arthritis patients in a clinical practice setting
Martin, RW
Wanke, LA
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 408 - 408
[2] Effects of alefacept on health-related quality of life in patients with psoriasis - Results from a randomized, placebo-controlled phase II trial
Ellis, CN
Mordin, MM
Adler, EY
[J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (02) : 131 - 139
[3] Adalimumab improves health-related quality of life in patients with fingernail psoriasis
Augustin, Matthias
Calimlim, Brian
Williams, David
Geng, Ziqian
Skup, Martha
Recih, Kristian
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB33 - AB33
[4] Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
Feldman, Steven R.
Thaci, Diamant
Gooderham, Melinda
Augustin, Matthias
de la Cruz, Claudia
Mallbris, Lotus
Buonanno, Marjorie
Tatulych, Svitlana
Kaur, Mandeep
Lan, Shuping
Valdez, Hernan
Mamolo, Carla
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (06) : 1162 - +
[5] Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial
Lebwohl, M.
Papp, K.
Han, C.
Schenkel, B.
Yeilding, N.
Wang, Y.
Krueger, G. G.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) : 137 - 146
[6] Ustekinumab Improves Health-Related Quality of Life in Korean and Taiwanese Patients With Moderate to Severe Psoriasis: Results from the PEARL Trial
Tsai, Tsen-Fang
Song, Michael
Shen, Yaung-Kaung
Schenkel, Brad
Choe, Yong-Beom
Kim, Nack-In
Lee, Joo-Heung
Lee, Ju-Hee
Song, Hae-Jun
Youn, Jai-Il
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (08) : 943 - 949
[7] Health-Related Quality of Life in Patients with Psoriasis
Jankovic, Slavenka
Raznatovic, Milena
Marinkovic, Jelena
Jankovic, Janko
Kocev, Nikola
Tomic-Spiric, Vesna
Vasiljevic, Nadja
[J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2011, 15 (01) : 29 - 36
[8] Etanercept (ENBREL) improves health-related quality of life in patients with psoriatic arthritis.
Wanke, LA
Gottlieb, AB
Mease, PJ
Kivitz, AJ
Cohen, SB
Burge, DJ
[J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S76 - S76
[9] Psoriasis patients show improved health-related quality of life when treated with etanercept (ENBREL)
Wanke, LA
Gottlieb, AB
Lowe, NJ
Lebsack, ME
[J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S120 - S120
[10] Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial
Ghia, Paolo
Coutre, Steven E.
Cheson, Bruce D.
Barrientos, Jacqueline C.
Hillmen, Peter
Pettitt, Andrew R.
Zelenetz, Andrew D.
Shreay, Sanatan
Hallek, Michael
Furman, Richard R.
[J]. HAEMATOLOGICA, 2020, 105 (10) : E519 - E522

← 1 2 3 4 5 →